Allogenic bone marrow transplantation for adults with primary myelodysplastic syndrome (MDS): Evaluation of prognostic factors

被引：0
|
作者：
Fung, HC
Shepherd, JD
Nantel, SH
Horsman, DE
Le, A
Forrest, DE
Toze, CL
Sutherland, HJ
Klingemann, HG
Hogge, DE
Barnett, MJ
机构：
[1] VANCOUVER HOSP & HLTH SCI CTR,BC CANC AGCY,DIV HEMATOL & LAB MED,LEUKEMIA BMT PROGRAM BC,VANCOUVER,BC V5Z 1M9,CANADA
[2] UNIV BRITISH COLUMBIA,VANCOUVER,BC V5Z 1M9,CANADA
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1909 / 1909
页数：1
相关论文
共 50 条
  • [1] Unrelated donor (URD) marrow transplantation for myelodysplastic syndrome (MDS): Analysis of prognostic factors and preparative regimens.
    Anderson, JE
    Anasetti, C
    Appelbaum, FR
    Hansen, JA
    Nash, RA
    Slattery, JT
    Storb, R
    BLOOD, 1995, 86 (10) : 1144 - 1144
  • [2] Prognostic factors in myelodysplastic syndromes following myeloablative allogenic bone marrow transplantation - A twelve year follow up study
    Lamba, R
    Abella, E
    Dansey, R
    Baynes, R
    Klein, J
    Karanes, C
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 37 - 38
  • [3] Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS
    DeWitte, T
    VanBiezen, A
    Hermans, J
    Labopin, M
    Runde, V
    Or, R
    Meloni, G
    Mauri, SB
    Carella, A
    Apperley, J
    Gratwohl, A
    Laporte, JP
    BLOOD, 1997, 90 (10) : 3853 - 3857
  • [4] Bone marrow hypocellularity and normal karyotype are the best prognostic factors in myelodysplastic syndromes (MDS)
    Pecorari, P
    Orlandini, D
    Sceusa, R
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 872 - 872
  • [5] A CASE OF POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN A CHILD WITH MYELODYSPLASTIC SYNDROME FOLLOWING ALLOGENIC BONE MARROW TRANSPLANTATION
    Heo, Seonhee
    Cho, Hye Jung
    Jeon, In-sang
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2010, 27 (01) : 59 - 64
  • [6] Allogeneic bone marrow transplantation (BMT) in children with de novo myelodysplastic syndrome (MDS).
    Frangoul, HA
    Gooley, TA
    Sanders, JE
    BLOOD, 1998, 92 (10) : 687A - 687A
  • [7] Prognostic impact of bone marrow fibrosis in myelodysplastic syndromes (MDS)
    Baghikar, S.
    Braunstein, S.
    Reinecke, P.
    Knipp, S.
    Haas, R.
    Hildebrandt, B.
    Gattermann, N.
    Germing, U.
    Schmidt-Graef, A.
    LEUKEMIA RESEARCH, 2007, 31 : S100 - S100
  • [8] Allogeneic bone marrow transplantation (BMT) for adults with secondary myelodysplastic syndrome (MDS) or secondary acute myelogenous leukemia (AML).
    Fung, HC
    Nantel, SH
    Phillips, GL
    Shepherd, JD
    Sutherland, HJ
    Klingemann, HG
    Toze, CL
    Reece, DE
    Barnett, MJ
    BLOOD, 1995, 86 (10) : 370 - 370
  • [9] Bone marrow transplantation (BMT) in children with myelodysplastic syndromes (MDS).
    Hoogerbrugge, PM
    Rossum, M
    Vries, E
    Gerritsen, EJA
    Weel, M
    Veer, ET
    Vossen, JMJJ
    BLOOD, 1995, 86 (10) : 353 - 353
  • [10] Allogeneic bone marrow transplantation (alloBMT) in myelodysplastic syndromes (MDS).
    Karanes, C
    Abella, E
    Du, W
    Klein, J
    Dansey, R
    Cassells, L
    Peters, W
    Baynes, R
    BLOOD, 1998, 92 (10) : 659A - 659A
12345